Hyperlipoproteinemia, hemostatic variables and thromboatherosclerosis

Area of Science:

• Cardiovascular Science
• Hematology
• Metabolic Disorders

Background:

• Hyperlipoproteinemia is increasingly associated with hemostatic imbalances.
• These imbalances can promote fibrin deposition and microthrombi formation within arterial walls.

Purpose of the Study:

• To investigate the relationship between endogenous hypertriglyceridemia and hemostatic variables.
• To explore the potential mechanisms linking hypertriglyceridemia to thromboatherosclerosis.

Main Methods:

• Clinical and laboratory observations were utilized.
• Plasma levels of fibrin stabilizing factor XIII, fibronectin, and fibrinolytic inhibitors were assessed.
• Activity of vitamin K-dependent clotting factors and antithrombin III levels were measured.

Main Results:

• Endogenous hypertriglyceridemia correlated with elevated plasma levels of fibrin stabilizing factor XIII, fibronectin, and fibrinolytic inhibitors.
• Fibrin clots showed increased resistance to fibrinolysis and enhanced adherence to the subendothelial layers.
• Increased activity of vitamin K-dependent clotting factors was observed, partially offset by high antithrombin III levels.

Conclusions:

• Accelerated lipoprotein synthesis and turnover in endogenous hypertriglyceridemia may stimulate hepatic production of specific hemostatic factors.
• The resulting hemostatic imbalance favors fibrin deposition and microthrombi, contributing to the localized and slow progression of thromboatherosclerosis.